Cada dioptría cuenta
revisión narrativa sobre evidencias y experiencias en la prevención de la progresión de la miopía
DOI:
https://doi.org/10.70313/2718.7446.v17.n04.377Palabras clave:
miopía, medio ambiente, estilo de vida, retina, prevención de la cegueraResumen
Dentro de la oftalmología, el conocimiento que tenemos sobre la enfermedad de la miopía se ha ideo incrementando en gran medida en las últimas cuatro a 5 décadas. Se están pudiendo responder diferentes preguntas de investigación y a la vez se están logrando terapéuticas que tienden a prevenir o enlentecer la progresión de la miopía. La miopía está aumentando en el mundo por diversos factores, sobre todo aquellos relacionados con estilo de vida y medio ambiente, siendo estos factores de riesgo modificables. Tener más miopía a lo largo de la vida significa también tener más riesgo de perder la visión por patologías secundarias. Por eso, cada dipotría cuenta y en este trabajo de revisión, se hará un breve repaso a las evidencias y experiencias desarrolladas en la práctica asistencial, den Mendoza, Argentina.
Citas
Au Eong KG, Tay TH, Lim MK. Education and myopia in 110,236 young Singaporean males. Singapore Med J 1993; 34(6): 489-492.
Saw SM, Wu HM, Seet B, et al. Academic achievement, close up work parameters, and myopia in Singapore military conscripts. Br J Ophthalmol 2001; 85(7): 855-860. doi:10.1136/bjo.85.7.855.
Martínez-Pérez C, Alvarez-Peregrina C, Brito R, Sánchez-Tena MA, Grupo de Investigação Optovisão Isec Lisboa. The evolution and the impact of refractive errors on academic performance: a pilot study of Portuguese school-aged children. Children (Basel) 2022; 9(6): 840. doi:10.3390/children9060840.
Zhang C, Li L, Jan C, Li X, Qu J. Association of school education with eyesight among children and adolescents [published correction appears in JAMA Netw Open 2022; 5(6):e2219315. doi: 10.1001/jamanetworkopen.2022.19315]. JAMA Netw Open 2022; 5(4): e229545. doi:10.1001/jamanetworkopen.2022.9545.
Kai JY, Li DL, Hu HH, Zhang XF, Pan CW. Impact of area-level socioeconomic and environmental measures on reduced visual acuity among children and adolescents. Invest Ophthalmol Vis Sci 2023; 64(7): 23. doi:10.1167/iovs.64.7.23.
Ding X, Morgan IG, Hu Y, et al. The causal effect of education on myopia: evidence that more exposure to schooling, rather than increased age, causes the onset of myopia. Invest Ophthalmol Vis Sci 2023; 64(4): 25. doi:10.1167/iovs.64.4.25.
Wu PC, Huang HM, Yu HJ, Fang PC, Chen CT. Epidemiology of myopia. Asia Pac J Ophthalmol (Phila) 2016; 5(6): 386-393. doi:10.1097/APO.0000000000000236.
Holden BA, Fricke TR, Wilson DA, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology 2016; 123(5): 1036-1042. doi:10.1016/j.ophtha.2016.01.006.
Crone RA. Manuel Straub and the Amsterdam School of Ophthalmology. Surv Ophthalmol 1996; 41(1): 90-95. doi:10.1016/s0039-6257(97)81998-4.
Flitcroft DI. Emmetropisation and the aetiology of refractive errors. Eye (Lond) 2014; 28(2): 169-179. doi:10.1038/eye.2013.276.
Rozema J, Dankert S, Iribarren R. Emmetropization and nonmyopic eye growth. Surv Ophthalmol 2023; 68(4): 759-783. doi:10.1016/j.survophthal.2023.02.002.
Schaeffel F, Swiatczak B. Mechanisms of emmetropization and what might go wrong in myopia. Vision Res 2024; 220: 108402. doi:10.1016/j.visres.2024.108402.
Troilo D. Experimental studies of emmetropization in the chick. Ciba Found Symp 1990; 155: 89-114. doi:10.1002/9780470514023.ch6.
Schaeffel F, Howland HC. Mathematical model of emmetropization in the chicken. J Opt Soc Am A 1988; 5(12): 2080-2086. doi:10.1364/josaa.5.002080.
Schaeffel F, Howland HC. Properties of the feedback loops controlling eye growth and refractive state in the chicken. Vision Res 1991; 31(4): 717-734. doi:10.1016/0042-6989(91)90011-s.
Mutti DO, Mitchell GL, Jones LA, et al. Axial growth and changes in lenticular and corneal power during emmetropization in infants. Invest Ophthalmol Vis Sci 2005; 46(9): 3074-3080. doi:10.1167/iovs.04-1040.
Jonas JB, Holbach L, Panda-Jonas S. Histologic differences between primary high myopia and secondary high myopia due to congenital glaucoma. Acta Ophthalmol 2016; 94(2): 147-153. doi:10.1111/aos.12937.
Bolande RP. Neurocristopathy: its growth and development in 20 years. Pediatr Pathol Lab Med 1997; 17(1): 1-25.
Ribeiro IM, Vale PJ, Tenedorio PA, Rodrigues PA, Bilhoto MA, Pereira HC. Ocular manifestations in fetal alcohol syndrome. Eur J Ophthalmol 2007; 17(1): 104-109. doi:10.1177/112067210701700114.
Seko Y, Azuma N, Takahashi Y, et al. Human sclera maintains common characteristics with cartilage throughout evolution. PLoS One 2008; 3(11): e3709. doi:10.1371/journal.pone.0003709.
Whitmore WG. Congenital and developmental myopia. Eye (Lond) 1992; 6 (Pt 4): 361-365. doi:10.1038/eye.1992.74.
Salik I, Rawla P. Marfan syndrome. En: StatPearls. Treasure Island (FL): StatPearls Publishing; Jan 23, 2023. https://www.ncbi.nlm.nih.gov/books/NBK537339/
Haarman AEG, Klaver CCW, Tedja MS, et al. Identification of rare variants involved in high myopia unraveled by whole genome sequencing. Ophthalmol Sci 2023; 3(4): 100303. Published 2023 Apr 6. doi:10.1016/j.xops.2023.100303.
Gharbiya M, Moramarco A, Castori M, et al. Ocular features in joint hypermobility syndrome/ehlers-danlos syndrome hypermobility type: a clinical and in vivo confocal microscopy study. Am J Ophthalmol 2012; 154(3): 593-600.e1. doi:10.1016/j.ajo.2012.03.023.
Nixon TRW, Richards AJ, Martin H, Alexander P, Snead MP. Autosomal recessive Stickler syndrome. Genes (Basel) 2022; 13(7): 1135. doi:10.3390/genes13071135.
Verkicharla P, Thakur S, Kammari P, Dhakal R, Das AV. Refractive development in individuals with ocular and oculocutaneous albinism. Int Ophthalmol 2022; 42(7): 2007-2015. doi:10.1007/s10792-021-02165-6.
Rada JA, Shelton S, Norton TT. The sclera and myopia. Exp Eye Res 2006; 82(2): 185-200. doi:10.1016/j.exer.2005.08.009.
Salomão MQ, Hofling-Lima AL, Gomes Esporcatte LP, et al. Ectatic diseases. Exp Eye Res 2021; 202: 108347. doi:10.1016/j.exer.2020.108347.
Nicholson DH, Galvis V. Criswick-Schepens syndrome (familial exudative vitreoretinopathy): study of a Colombian kindred. Arch Ophthalmol 1984; 102(10): 1519-1522. doi:10.1001/archopht.1984.01040031239027.
Limwattanayingyong J, Amornpetchsathaporn A, Chainakul M, Grzybowski A, Ruamviboonsuk P. The association between environmental and social factors and myopia: a review of evidence from COVID-19 pandemic. Front Public Health 2022; 10: 918182. doi:10.3389/fpubh.2022.918182.
Dutheil F, Oueslati T, Delamarre L, et al. Myopia and near work: a systematic review and meta-analysis. Int J Environ Res Public Health 2023; 20(1): 875. doi:10.3390/ijerph20010875.
Li X, Li L, Qin W, et al. Urban living environment and myopia in children. JAMA Netw Open 2023; 6(12): e2346999. Published 2023 Dec 1. doi:10.1001/jamanetworkopen.2023.46999.
Biswas S, El Kareh A, Qureshi M, et al. The influence of the environment and lifestyle on myopia. J Physiol Anthropol 2024; 43(1): 7. doi:10.1186/s40101-024-00354-7.
Yang Y, Liao H, Zhao L, et al. Green space morphology and school myopia in China [published correction appears in JAMA Ophthalmol 2024; 142(4):393. doi: 10.1001/jamaophthalmol.2024.0081]. JAMA Ophthalmol 2024; 142(2): 115-122. doi:10.1001/jamaophthalmol.2023.6015.
Ohno-Matsui K, Wu PC, Yamashiro K, et al. IMI Pathologic Myopia [published correction appears in Invest Ophthalmol Vis Sci 2021; 62(7): 17. doi: 10.1167/iovs.62.7.17]. Invest Ophthalmol Vis Sci 2021; 62(5): 5. doi:10.1167/iovs.62.5.5.
Jiang F, Wang D, Xiao O, et al. Four-year progression of myopic maculopathy in children and adolescents with high myopia. JAMA Ophthalmol 2024; 142(3): 180-186. doi:10.1001/jamaophthalmol.2023.6319.
Tokoro T, Funata M, Akazawa Y. Influence of intraocular pressure on axial elongation. J Ocul Pharmacol 1990; 6(4): 285-291. doi:10.1089/jop.1990.6.285.
Jensen H. Myopia progression in young school children: a prospective study of myopia progression and the effect of a trial with bifocal lenses and beta blocker eye drops. Acta Ophthalmol Suppl (1985) 1991; (200): 1-79.
Hosaka A. Myopia prevention and therapy. The role of pharmaceutical agents. Japanese studies. Acta Ophthalmol Suppl (1985) 1988; 185: 130-131. doi:10.1111/j.1755-3768.1988.tb02687.x.
Goldschmidt E. Myopia in humans: can progression be arrested? Ciba Found Symp 1990; 155: 222-234. doi:10.1002/9780470514023.ch13.
Ohno-Matsui K, Scholl HPN. Having one of the fastest growing unmet needs in ophthalmology reflected in editorial activities: myopia. Ophthalmic Res 2022; 65(1): 1-3. doi:10.1159/000521194.
Kotlik CA. Oftalmología basada en evidencia: ciencia versus Industria y pseudociencia. Rev Arg Oftalmol Infant 2020; 1(1): 23-27. https://saoi.org.ar/raoi/.
Chua WH, Balakrishnan V, Chan YH, et al. Atropine for the treatment of childhood myopia. Ophthalmology 2006; 113(12): 2285-2291. doi:10.1016/j.ophtha.2006.05.062.
Chia A, Chua WH, Cheung YB, et al. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2). Ophthalmology 2012; 119(2): 347-354. doi:10.1016/j.ophtha.2011.07.031.
Ha A, Kim SJ, Shim SR, Kim YK, Jung JH. Efficacy and safety of 8 atropine concentrations for myopia control in children: a network meta-analysis. Ophthalmology 2022; 129(3): 322-333. doi:10.1016/j.ophtha.2021.10.016.
Yam JC, Jiang Y, Tang SM, et al. Low-concentration atropine for myopia progression (LAMP) study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control. Ophthalmology 2019; 126(1): 113-124. doi:10.1016/j.ophtha.2018.05.029.
Zadnik K, Schulman E, Flitcroft I, et al. Efficacy and safety of 0.01% and 0.02% atropine for the treatment of pediatric myopia progression over 3 years: a randomized clinical trial [published correction appears in JAMA Ophthalmol 2023; 141(10): 1005. doi:10.1001/jamaophthalmol.2023.4206]. JAMA Ophthalmol 2023; 141(10): 990-999. doi:10.1001/jamaophthalmol.2023.2097.
Kotlik CA. Mi paper favorito. MO: Médico Oftalmólogo 2018; 31(1): 38. https://issuu.com/caoarg/docs/revista_mo__8_print
Chia A, Lu QS, Tan D. Five-year clinical trial on atropine for the treatment of myopia 2: myopia control with atropine 0.01% eyedrops. Ophthalmology 2016; 123(2): 391-399. doi:10.1016/j.ophtha.2015.07.004.
Kotlik CA. La disminución de la progresión de la miopía en niños. Oftalmonews 2020; 7(27): 30-37. https://issuu.com/fibertel23/docs/_oftalmonews_n_27-
Myopia Symposium Argentina 2020: What do we know about myopia? An update on basic and clinical research (2020, Nov. 7). English: https://www.youtube.com/watch?v=rRV_OVefUuQ Spanish: https://www.youtube.com/watch?v=VD7WiR91Q8c (español)
Kotlik CA, Zaldivar R, Szeps A, De Tomas M, Impagliazzo R, Iribarren R. Myopia and outdoor sports in university students of Mendoza, Argentina. Oftalmol Clín Exp 2021; 14(2): 96-101. https://doi.org/10.70313/2718.7446.v14.n2.56
Iribarren R, De Tomas M, Kotlik CA, Szeps A, Impagliazzo R. Nuevos anteojos para control de la miopía. Oftalmol Clín Exp 2022; 15(2): e240-e243. https://doi.org/10.70313/2718.7446.v15.n2.156.
Iribarren R, Galán MM, Szeps A, Fernández Irigaray L, Kotlik CA, Rodríguez G, Aguirre R. Consenso sobre el manejo de la miopía en la edad de progresión. Oftalmol Clín Exp 2022; 15(2): e115-e136. https://doi.org/10.70313/2718.7446.v15.n2.142.
Szeps A, De Tomas M, Kotlik CA, Iribarren R. Axial length changes with diffusion optics multiple segments (DOMS) spectacles for myopia control. Oftalmol Clín Exp 2023; 16(2): e148-e154. https://revistaoce.com/index.php/revista/article/view/228/383
Kotlik CA, Rodríguez G, Szeps A, Fernández Irigaray L, Iribarren R, Aguirre R, Galán MM. Tratamiento farmacológico de la miopía. RAOI: Rev Arg Oftalmol Infant 2023; 4(2): 24-27.
Kotlik CA, Rodríguez G, Szeps A, Fernández Irigaray L, Iribarren R, Aguirre R, Galán MM. Prevención de la miopía. RAOI: Rev Arg Oftalmol Infant 2023; 4(1): 24-26.
Iribarren R, Szeps A, Kotlik CA, Laurencio L, De Tomas M, Impagliazzo R, Martin G. Short-term axial length changes in myopic eyes induced by defocus spectacles for myopia control. Photonics 2023; 10(6): 668.
Kotlik CA, Iribarren R, De Tomas, M. Controversias en progresión de la miopía. Oftalmonews 2022; 9(38): 34-36
Brown DM, Mazade R, Clarkson-Townsend D, Hogan K, Datta Roy PM, Pardue MT. Candidate pathways for retina to scleral signaling in refractive eye growth. Exp Eye Res 2022; 219: 109071. doi:10.1016/j.exer.2022.109071.
Muralidharan AR, Lança C, Biswas S, et al. Light and myopia: from epidemiological studies to neurobiological mechanisms. Ther Adv Ophthalmol 2021; 13: 25158414211059246. doi:10.1177/25158414211059246.
Zhang P, Zhu H. Light signaling and myopia development: a review. Ophthalmol Ther 2022; 11(3): 939-957. doi:10.1007/s40123-022-00490-2.
Jawaid I, Saunders K, Hammond CJ, Dahlmann-Noor A, Bullimore MA. Low concentration atropine and myopia: a narrative review of the evidence for United Kingdom based practitioners. Eye (Lond) 2024; 38(3): 434-441. doi:10.1038/s41433-023-02718-2.
Morgan IG, Wu PC, Ostrin LA, et al. IMI risk factors for myopia. Invest Ophthalmol Vis Sci 2021; 62(5): 3. doi:10.1167/iovs.62.5.3.
Zhu Z, Chen Y, Tan Z, Xiong R, McGuinness MB, Müller A. Interventions recommended for myopia prevention and control among children and adolescents in China: a systematic review. Br J Ophthalmol 2023; 107(2): 160-166. doi:10.1136/bjophthalmol-2021-319306.
Hiraoka T. Myopia Control With Orthokeratology: A Review. Eye Contact Lens 2022; 48(3): 100-104. doi:10.1097/ICL.0000000000000867.
De Tomas M, Szeps A, Martín G, et al. Retinal shadows produced by myopia control spectacles. Ophthalmic Physiol Opt 2024; 44(1): 214-218. doi:10.1111/opo.13228.
Aleman AC, Wang M, Schaeffel F. Reading and myopia: contrast polarity matters. Sci Rep 2018; 8(1): 10840. doi:10.1038/s41598-018-28904-x.
Amorim-de-Sousa A, Chakraborty R, Collins MJ, et al. Blue light stimulation of the blind spot in human: from melanopsin to clinically relevant biomarkers of myopia. Bioelectron Med 2024; 10(1): 26. doi:10.1186/s42234-024-00159-0.
Cougnard-Gregoire A, Merle BMJ, Aslam T, et al. Blue light exposure: ocular hazards and prevention-a narrative review. Ophthalmol Ther 2023; 12(2): 755-788. doi:10.1007/s40123-023-00675-3.
Jung SG, Hwang K, Hwang YJ. Beauty pageants in the Japanese colonial era of Korea (1931 and 1940). J Craniofac Surg 2024; 35(7): e618-e620. doi:10.1097/SCS.0000000000010226.
Lapo P, Inmutto N, Tanaka H, Suksom D. Cardiorespiratory burden of brass neck coils placed on Kayan Karen long-neck women of Thailand. Appl Physiol Nutr Metab 2019; 44(8): 894-901. doi:10.1139/apnm-2019-0083.
Tantaleán H, Stanish C, Rodríguez A, Pérez K. The final days of Paracas in Cerro del Gentil, Chincha Valley, Peru. PLoS One 2016; 11(5): e0153465. doi:10.1371/journal.pone.0153465.
Kotlik CA. Progresión de la miopía. Educaplay, 2024. https://www.educaplay.com/learning-resources/9272371-progresion_de_la_miopia.html
Gutiérrez García AA. Todo lo cercano se aleja: revisión sobre el impacto de la miopía de Borges y otras alteraciones oculares en su obra literaria. Oftalmol Clín Exp 2024; 17(2): e180-e188. https://doi.org/10.70313/2718.7446.v17.n02.320
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2024 Consejo Argentino de Oftalmología
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
Con esta licencia no se permite un uso comercial de la obra original, ni la generación de obras derivadas. Las licencias Creative Commons permiten a los autores compartir y liberar sus obras en forma legal y segura.
